10-Q
PERIOD ENDING SEPTEMBER 30, 2002
- Company
- Oncotelic Therapeutics, Inc.
- Filed
- November 14, 2002
- Period of Report
- September 30, 2002
- Accession Number
- 0000908259-02-000012
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →